[Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
Kazuaki Tanabe(Hiroshima University), Tetsuya Toge(Hiroshima University), Kazuhiro Yoshida(Kyoto Institute of Technology), Jun Hihara(Hiroshima City Asa Citizens Hospital), Koji Ohta(Hiroshima University), Kei Ukon(Hiroshima University), Yoichi Hamai(Hiroshima University)
PubMed
August 1, 2005
Cited by 1
Related Papers
Cancer immunoediting from immune surveillance to immune escape
|Immunology|2007|1k
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011‐2017
|Annals of Gastroenterological Surgery|2019|210
The long-term survival of stage IV gastric cancer patients with conversion therapy
|Gastric Cancer|2017|168
Surgical outcomes in gastroenterological surgery in Japan: Report of the National Clinical Database 2011–2019
|Annals of Gastroenterological Surgery|2021|146